Literature DB >> 26244319

Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer.

Yong He.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26244319     DOI： 10.1056/NEJMc1506831

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.

Authors:  Tyler Lazaro; Priscilla K Brastianos
Journal:  CNS Oncol       Date:  2017-04

Review 2.  Management of hyperglycemia from epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeting T790M-mediated resistance.

Authors:  Jeryl Villadolid; Jennifer L Ersek; Mei Ka Fong; Lindsey Sirianno; Ellen S Story
Journal:  Transl Lung Cancer Res       Date:  2015-10

3.  Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR.

Authors:  Annamaria Siggillino; Paola Ulivi; Luigi Pasini; Maria Sole Reda; Elisa Chiadini; Francesca Romana Tofanetti; Sara Baglivo; Giulio Metro; Lucio Crinó; Angelo Delmonte; Vincenzo Minotti; Fausto Roila; Vienna Ludovini
Journal:  Diagnostics (Basel)       Date:  2020-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.